Lung cancer, according to the American Cancer Society, is the leading cause of cancer death in the country.  Nearly 175,00 Americans will be affected by lung cancer and the vast majority will eventually lose their battle with the disease largely because it is discovered too late for any type of treatment to be effective. But, Dr. Christopher Leary of Radiologic Associates in Bristol, said that if lung cancer is caught in its early stages, a patient’s chances of survival are drastically improved. Leary added that spiral computed tomography CT scans are able to provide early detection.

Pharmacyclics said Friday it submitted a new drug application with the U.S. Food and Drug Administration for Xcytrin.The company is seeking an indication for treatment of patients with non-small cell lung cancer that has metastasized to the brain.

Once people have been diagnosed with lung cancer they might think it pointless to stop smoking, but in fact it’s not too late to benefit from quitting, a new study shows.

Taking pomegranate fruit extract may help stop growth of lung cancer in humans, a new study suggests.  Early studies have suggested that drinking pomegranate juice may help prevent progression of prostate cancer.

There may be another reason for pregnant and nursing women to eat a nutritious diet that includes generous amounts of cruciferous vegetables like broccoli and cabbage – it could help protect their children from cancer, both as infants and later in life.

The Catholic Diocese of Rockford, IL announces that Bishop Thomas G. Doran is recovering from surgery at the Mayo Clinic in Rochester, Minn. Approximately one-fourth of his left lung was removed during a four-hour surgery Thursday, Dec. 14. Two spots, one in each lung, were discovered during his annual routine physical earlier this month.

Dr McKeage was running a clinical trial using an experimental drug on non-small cell lung cancer patients like Mr Torrens.

The drug was DMXAA, developed at the Auckland Cancer Society Research Centre by Professors Bruce Baguley and Bill Denny.

In this new study, the researchers analyzed the costs of the two treatment approaches to determine which one offered the best value for the money. They estimated the costs of treatment and related expenses, such as medical care for people who survived their cancer.

Surgery remains confined to localized NSCLC patients and the majority of patients are diagnosed in advanced stages of the disease, where platinum analogue-based pharmacotherapy is the mainstay of treatment. The introduction of third-generation cytotoxics has raised the hope of significantly improving efficacy, but prognosis is still poor, and the survival rate has remained relatively stagnant.

IU Med Center doctor shows middle-schoolers the cancer risks